Tag : VERTEPORFIN

Current treatments for wet age-related macular degeneration (wAMD) include the use of vascular endothelial growth factor (VEGF) inhibitors and the use of photodynamic therapy (PDT). Combination of these therapies may offer significant improvements in visual acuity but safety concerns remain. Researchers from the University of Hong Kong Faculty of Medicine (HKUMed) reported the development of a novel and minimally invasive approach to wAMD treatment, by intravenously administering a photoactivatable nanosystem and irradiating the diseased eyes.